SCHEMBL9535095

SCHEMBL9535095

O=c1cc(N2CCOCC2)oc2cc(OCCOc3ccccc3)ccc12

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PRKDC P78527 17/20 1.00
P2RY12 Q9H244 3/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31061456 0.90 PRKDC (1.00) PRKDC
SCHEMBL31061551 0.88 PRKDC (1.00) PRKDCP2RY12
SCHEMBL3536307 0.88 PRKDC (1.00) PRKDCP2RY12
SCHEMBL3537201 0.87 PRKDC (1.00) PRKDCP2RY12
SCHEMBL31061029 0.87 PRKDC (1.00) PRKDCP2RY12
SCHEMBL3653469 0.85 PRKDC (0.87) PRKDCP2RY12
SCHEMBL3540076 0.85 PRKDC (1.00) PRKDCP2RY12
SCHEMBL7321292 0.84 P2RY12 (0.84) PRKDCP2RY12
SCHEMBL3535894 0.84 PRKDC (1.00) PRKDCP2RY12
SCHEMBL9539932 0.83 P2RY12 (1.00) PRKDCP2RY12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0525123-A1 ANTIATHEROSCLEROTIC AND ANTITHROMBOTIC 1-BENZOPYRAN-4-ONES AND 2-AMINO-1,3-BENZOXAZINE-4-ONES. UPJOHN CO (US) 1993-02-03 EP claimed
EP-4662319-A2 PERSONALIZED CRISPR PROFILING FOR CANCER Integrate Bioscience LLC (US) 2025-12-17 EP disclosed
WO-2024168301-A2 PERSONALIZED CRISPR PROFILING FOR CANCER FUNCTION ONCOLOGY, INC. (US) 2024-08-15 WO disclosed